Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus

• 收藏
• 分享

专利权人:

Actogenix NV

发明人:

Pieter Rottiers,Veerle Snoeck

申请号：

US13720967

公开号：

US08524246B2

申请日:

2012.12.19

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention relates to the treatment of autoimmune and allergic diseases by mucosal delivery by micro-organism, in particular Lactococcus lactis, of secreted immunodominant antigens.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/